The estimated Net Worth of Timothy P. Moran is at least $1.67 Миллион dollars as of 19 November 2021. Mr. Moran owns over 10,000 units of Motus GI Inc stock worth over $14,964 and over the last 6 years he sold MOTS stock worth over $0. In addition, he makes $1,659,360 as Chief Executive Officer и Director at Motus GI Inc.
Timothy has made over 7 trades of the Motus GI Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of MOTS stock worth $5,200 on 19 November 2021.
The largest trade he's ever made was buying 15,000 units of Motus GI Inc stock on 19 November 2018 worth over $52,200. On average, Timothy trades about 4,222 units every 73 days since 2018. As of 19 November 2021 he still owns at least 482,701 units of Motus GI Inc stock.
You can see the complete history of Mr. Moran stock trades at the bottom of the page.
Timothy P. Moran serves as Chief Executive Officer, Director of the Company. Prior to joining us, from 2015 to September 2018, Mr. Moran served as President of the Americas, ConvaTec Group Plc (LON: CTEC) (“ConvaTec”), an international medical products and technologies company, offering products and services in the areas of wound and skin care, ostomy care, continence and critical care and infusion devices. Prior to his employment at ConvaTec, Mr. Moran held roles in sales, marketing and general management over the course of eighteen years at Covidien plc (“Covidien”), an Irish-headquartered global health care products company and manufacturer of medical devices and supplies. While at Covidien, until 2015, Mr. Moran served simultaneously as VP and General Manager of both the SharpSafety and Monitoring & Operating Room divisions. Following the 2015 acquisition of Covidien by Medtronic (NYSE:MDT), Mr. Moran was named the Global Vice President and General Manager of the Patient Care and Safety Division. Mr. Moran also served on the CEO Advisory Council for Advanced Medical Technology Association (AdvaMed), a medical device trade association. Mr. Moran earned a B.A. in Organizational Communication at The State University of New York at Geneseo. Mr. Moran was selected as a director because of his broad commercial experience and leadership in the medical technology sector.
As the Chief Executive Officer и Director of Motus GI Inc, the total compensation of Timothy Moran at Motus GI Inc is $1,659,360. There are no executives at Motus GI Inc getting paid more.
Timothy Moran is 48, he's been the Chief Executive Officer и Director of Motus GI Inc since 2018. There are 7 older and 2 younger executives at Motus GI Inc. The oldest executive at Motus GI Holdings Inc is Samuel Nussbaum, 71, who is the Independent Director.
Timothy's mailing address filed with the SEC is 1301 E Broward Blvd, Fort Lauderdale, FL 33301, USA.
Over the last 7 years, insiders at Motus GI Inc have traded over $2,638,819 worth of Motus GI Inc stock and bought 3,952,265 units worth $13,986,863 . The most active insiders traders include Advisors Llcperceptive Life..., Larry Noracle Partners Lp F... и David P Hochman. On average, Motus GI Inc executives and independent directors trade stock every 33 days with the average trade being worth of $4,105. The most recent stock trade was executed by Andrew Lawrence Taylor on 19 November 2021, trading 2,000 units of MOTS stock currently worth $1,020.
motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.
Motus GI Inc executives and other stock owners filed with the SEC include: